Interleukin-2-Inducible T-cell Kinase (ITK) signaling regulates non-canonical regulatory T cells

被引：0
|
作者：
Mammadli, Mahinbanu [1 ]
Harris, Rebecca [1 ]
May, Adriana [1 ]
Gentile, Teresa [1 ]
Karimi, Mobin A. [1 ]
机构：
[1] SUNY Upstate Med Univ, Syracuse, NY 13210 USA
来源：
JOURNAL OF IMMUNOLOGY | 2021年 / 206卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Identification of a New Inhibitor That Stabilizes Interleukin-2-Inducible T-Cell Kinase in Its Inactive Conformation
    Hantani, Rie
    Hanawa, Saya
    Oie, Shohei
    Umetani, Kayo
    Sato, Toshihiro
    Hantani, Yoshiji
    SLAS DISCOVERY, 2019, 24 (08) : 854 - 862
  • [22] Interleukin-2-inducible T-cell kinase expression and relation to disease severity in systemic lupus erythematosus
    Xu, Wang-Dong
    Su, Lin-Chong
    Xie, Qi-Bing
    Zhao, Yi
    Liu, Yi
    CLINICA CHIMICA ACTA, 2016, 463 : 11 - 17
  • [23] CPI-818: A selective inhibitor of interleukin-2-inducible T-cell kinase (ITK) that inhibits T-cell receptor signaling, promotes Th1 skewing, and achieves objective tumor responses when administered to dogs with T cell lymphomas
    Janc, James W.
    Hill, Craig M.
    Ng, Patrick P.
    Hoston, Andrew N.
    Madriaga, Antonett
    Dao-Pick, Trang P.
    Yeung, Kitman S.
    Hudson, Ryan
    Beausoleil, Anne-Marie
    Bradley, Erin
    Verner, Erik
    Thamm, Douglas H.
    Miller, Richard A.
    Buggy, Joseph J.
    CANCER RESEARCH, 2019, 79 (13)
  • [24] Interleukin-2-inducible T-cell kinase inhibition to block NF-κB signaling exerts anti-tumor effects and enhances chemotherapy in NK/ T-cell lymphoma
    Cao, Jiaowu
    Hu, Dingyao
    Yu, Hui
    Xie, Yan
    Mi, Lan
    Ye, Yingying
    Deng, Mi
    Zhang, Weimin
    Li, Miaomiao
    Wang, Dedao
    Qi, Fei
    Wu, Jiajin
    Song, Yuqin
    Zhu, Jun
    Ding, Ning
    CANCER LETTERS, 2025, 618
  • [25] Cpi-818, an Oral Interleukin-2-Inducible T-Cell Kinase Inhibitor, Is Well-Tolerated and Active in Patients with T-Cell Lymphoma
    Khodadoust, Michael S.
    Feldman, Tatyana A.
    Yoon, Dok Hyun
    Yannakou, Costas K.
    Radeski, Dejan
    Kim, Youn H.
    Mehta-Shah, Neha
    Khot, Amit
    Wilcox, Ryan A.
    Kim, Won Seog
    Horwitz, Steven M.
    Buggy, Joseph J.
    Hotson, Andrew
    Hill, Craig M.
    Munneke, Brian
    Mahabhashyam, Suresh
    Miller, Richard A.
    Janc, James W.
    Mobasher, Mehrdad
    BLOOD, 2020, 136
  • [26] A Role for Hydration in Interleukin-2 Inducible T Cell Kinase (Itk) Selectivity
    Knegtel, Ronald M. A.
    Robinson, Daniel D.
    MOLECULAR INFORMATICS, 2011, 30 (11-12) : 950 - 959
  • [27] Discovery of 7H-pyrrolo[2,3-d]pyrimidine derivatives as selective covalent irreversible inhibitors of interleukin-2-inducible T-cell kinase (Itk)
    Tang, Guanghui
    Liu, Lihong
    Wang, Xueying
    Pan, Zhengying
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 173 : 167 - 183
  • [28] Atypical Clinical Course in Pediatric Hodgkin Lymphoma: Association With Germline Mutations in Interleukin-2-inducible T-Cell Kinase
    Alme, Charlotte
    Satwani, Prakash
    Alobeid, Bachir
    Bhagat, Govind
    Kelly, Kara M.
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2015, 37 (07) : 507 - 508
  • [29] Molecular Characteristics of CTA056, a Novel Interleukin-2-Inducible T-Cell Kinase Inhibitor that Selectively Targets Malignant T Cells and Modulates Oncomirs
    Guo, Wenchang
    Liu, Ruiwu
    Ono, Yoko
    Ma, Ai-Hong
    Martinez, Anthony
    Sanchez, Eduardo
    Wang, Yan
    Huang, Wenzhe
    Mazloom, Anisha
    Li, Jixian
    Ning, Jinying
    Maverakis, Emanual
    Lam, Kit S.
    Kung, Hsing-Jien
    MOLECULAR PHARMACOLOGY, 2012, 82 (05) : 938 - 947
  • [30] T-Cell Signaling Regulated by the Tec Family Kinase, Itk
    Andreotti, Amy H.
    Schwartzberg, Pamela L.
    Joseph, Raji E.
    Berg, Leslie J.
    COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY, 2010, 2 (07): : a002287
12345